Back to
Barclays plc
FUSN
Showing 0 of 2 quarters
Position history for
Barclays plc's holdings in FUSION PHARMACEUTICALS INC
As of its Q1 2024 13F, Barclays held 8,683 shares of FUSN (Fusion Pharmaceuticals), worth $185,122.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of FUSN: Federated Hermes, Inc., FIL Ltd, Pentwater Capital Management LP, Canada Pension Plan Investment Board